Development of a Scalable Synthesis of Mevidalen (LY3154207), an Orally Available Positive Allosteric Modulator of the Human Dopamine D1 Receptor

IF 3.1 3区 化学 Q2 CHEMISTRY, APPLIED
Jeffery Richardson*, Kevin P. Cole, Amy C. DeBaillie, Junliang Hao, Jared Piper, Peter Houghton, John Rizzo, Mo Jia, Peng Liu, Ping Huang, Katarina Kadlecikova, Conchita F. Garcia, Daniel S. Richards
{"title":"Development of a Scalable Synthesis of Mevidalen (LY3154207), an Orally Available Positive Allosteric Modulator of the Human Dopamine D1 Receptor","authors":"Jeffery Richardson*,&nbsp;Kevin P. Cole,&nbsp;Amy C. DeBaillie,&nbsp;Junliang Hao,&nbsp;Jared Piper,&nbsp;Peter Houghton,&nbsp;John Rizzo,&nbsp;Mo Jia,&nbsp;Peng Liu,&nbsp;Ping Huang,&nbsp;Katarina Kadlecikova,&nbsp;Conchita F. Garcia,&nbsp;Daniel S. Richards","doi":"10.1021/acs.oprd.0c00229","DOIUrl":null,"url":null,"abstract":"<p >The evolution from early medicinal chemistry to large-scale production of the chemical synthesis of Lilly D1-positive allosteric modulator (PAM) mevidalen (LY3154207) and its hydroxybenzoate co-crystal is outlined. The issues and steps taken to resolve them are outlined across several generations of synthesis, including unexpected issues that arose during cryogenic addition of MeLi to a key imine intermediate and the use of flow chemistry to enable large-scale production. Ultimately, a process that was used to deliver &gt;100 kg of API to support ongoing clinical trials is described.</p>","PeriodicalId":55,"journal":{"name":"Organic Process Research & Development","volume":"24 11","pages":"2549–2564"},"PeriodicalIF":3.1000,"publicationDate":"2020-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1021/acs.oprd.0c00229","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Organic Process Research & Development","FirstCategoryId":"92","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acs.oprd.0c00229","RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, APPLIED","Score":null,"Total":0}
引用次数: 6

Abstract

The evolution from early medicinal chemistry to large-scale production of the chemical synthesis of Lilly D1-positive allosteric modulator (PAM) mevidalen (LY3154207) and its hydroxybenzoate co-crystal is outlined. The issues and steps taken to resolve them are outlined across several generations of synthesis, including unexpected issues that arose during cryogenic addition of MeLi to a key imine intermediate and the use of flow chemistry to enable large-scale production. Ultimately, a process that was used to deliver >100 kg of API to support ongoing clinical trials is described.

Abstract Image

可扩展合成人多巴胺D1受体口服正变构调节剂Mevidalen (LY3154207)的研究
概述了Lilly d1阳性变构调节剂(PAM) mevidalen (LY3154207)及其羟基苯甲酸盐共晶的化学合成从早期药物化学到大规模生产的演变过程。本文概述了几代合成中存在的问题和解决这些问题的步骤,包括在低温添加MeLi到关键亚胺中间体过程中出现的意想不到的问题,以及使用流动化学来实现大规模生产。最后,描述了用于提供100公斤原料药以支持正在进行的临床试验的过程。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.90
自引率
14.70%
发文量
251
审稿时长
2 months
期刊介绍: The journal Organic Process Research & Development serves as a communication tool between industrial chemists and chemists working in universities and research institutes. As such, it reports original work from the broad field of industrial process chemistry but also presents academic results that are relevant, or potentially relevant, to industrial applications. Process chemistry is the science that enables the safe, environmentally benign and ultimately economical manufacturing of organic compounds that are required in larger amounts to help address the needs of society. Consequently, the Journal encompasses every aspect of organic chemistry, including all aspects of catalysis, synthetic methodology development and synthetic strategy exploration, but also includes aspects from analytical and solid-state chemistry and chemical engineering, such as work-up tools,process safety, or flow-chemistry. The goal of development and optimization of chemical reactions and processes is their transfer to a larger scale; original work describing such studies and the actual implementation on scale is highly relevant to the journal. However, studies on new developments from either industry, research institutes or academia that have not yet been demonstrated on scale, but where an industrial utility can be expected and where the study has addressed important prerequisites for a scale-up and has given confidence into the reliability and practicality of the chemistry, also serve the mission of OPR&D as a communication tool between the different contributors to the field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信